# Patheon Pharmaceuticals Inc. - Inspection Records Source: https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b > Inspection records and compliance data for Patheon Pharmaceuticals Inc. in Cincinnati, Ohio. Access full analysis and detailed observations. --- ## Details - Name: Patheon Pharmaceuticals Inc. - FEI Number: 1510437 - City: Cincinnati - State: Ohio - Country Name: United States - Address Line 1: 2110 E Galbraith Rd - Zip Code: 45237 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK ## Related Documents - [CRL - Patheon Pharmaceuticals Inc. - Unknown Date](https://www.keypedia.com/records/crl/patheon-pharmaceuticals-inc/72df384b-5db2-4b05-9a05-774fc04c731c) — source: FDA, date: Invalid Date - [483 - Patheon Pharmaceuticals Inc. - 2025-09-26](https://www.keypedia.com/records/483/patheon-pharmaceuticals-inc/46555dc2-dbe8-44e5-949c-8dcfdc5cf1f1) — source: FDA, date: September 26, 2025 - [FDA Inspection 1281564 - Patheon Pharmaceuticals Inc. - 2025-09-26](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/c9bd372c-afe5-4c32-b233-b6dd8b833371) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 26, 2025 - [FDA Inspection 1281564 - Patheon Pharmaceuticals Inc. - 2025-09-26](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/ee9dd4e9-579e-445b-8896-014b387bbc11) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 26, 2025 - [FDA Inspection 1281564 - Patheon Pharmaceuticals Inc. - 2025-09-26](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/289959a6-4e3e-49e7-8b70-b60a6ba2371b) — source: FDA, date: September 26, 2025 - [FDA Inspection 1281564 - Patheon Pharmaceuticals Inc. - 2025-09-26](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/aec115eb-cc7d-4c99-bfd1-e835f2c03254) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 26, 2025 - [FDA Inspection 1211249 - Patheon Pharmaceuticals Inc. - 2023-07-24](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/56deddd1-13e4-46ec-a674-39bafbb99da6) — source: FDA, date: July 24, 2023 - [FDA Inspection 1204466 - Patheon Pharmaceuticals Inc. - 2023-04-21](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/3de4da01-f6e4-44da-9ab7-6f8f8d719fe2) — classification: No Action Indicated (NAI), source: FDA, date: April 21, 2023 - [EIR - Patheon Pharmaceuticals Inc. - 2020-01-14](https://www.keypedia.com/records/eir/patheon-pharmaceuticals-inc/cdf1e925-9a0e-4d8c-8130-30ad1223c5c7) — source: FDA, date: January 14, 2020 - [FDA Inspection 1117783 - Patheon Pharmaceuticals Inc. - 2020-01-14](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/e9537fb1-c8d0-46cf-ac68-0779db019213) — classification: No Action Indicated (NAI), source: FDA, date: January 14, 2020 - [EIR - Patheon Pharmaceuticals Inc. - 2019-12-13](https://www.keypedia.com/records/eir/patheon-pharmaceuticals-inc/50927805-589f-47bc-9191-0bf4eb7b953a) — source: FDA, date: December 13, 2019 - [EIR - Patheon Pharmaceuticals Inc. - 2018-02-14](https://www.keypedia.com/records/eir/patheon-pharmaceuticals-inc/ab7af48a-5395-4a10-a459-61234e9edc2d) — source: FDA, date: February 14, 2018 - [483 - Patheon Pharmaceuticals Inc. - 2018-02-14](https://www.keypedia.com/records/483/patheon-pharmaceuticals-inc/9eb0faa4-5afb-406b-95a3-d30d918be7c5) — source: FDA, date: February 14, 2018 - [FDA Inspection 1040994 - Patheon Pharmaceuticals Inc. - 2018-02-14](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/8d2c708c-359e-4f1c-a3f7-515d29d5ca1e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 14, 2018 - [FDA Inspection 1003802 - Patheon Pharmaceuticals Inc. - 2017-03-02](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/401d460c-0b1b-4e07-a8b9-43701e72162b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 2, 2017 - [EIR - Patheon Pharmaceuticals Inc. - 2017-03-01](https://www.keypedia.com/records/eir/patheon-pharmaceuticals-inc/ffc3b2b8-6ab9-456d-b78d-b6e30aeea171) — source: FDA, date: March 1, 2017 - [FDA Inspection 966241 - Patheon Pharmaceuticals Inc. - 2016-03-11](https://www.keypedia.com/records/fda_inspections/patheon-pharmaceuticals-inc/9582e571-bf16-4e03-9491-a2a05cf7cee7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 11, 2016 - [483 - Patheon Pharmaceuticals Inc. - 2015-08-21](https://www.keypedia.com/records/483/patheon-pharmaceuticals-inc/ff3273cc-2273-45b6-8a2e-d844f29091ab) — source: FDA, date: August 21, 2015 ## Related Companies - [Novartis Pharma Stein AG](https://www.keypedia.com/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b) - [FUJIFILM Diosynth Biotechnologies Denmark ApS](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-denmark-aps/513b3c42-1517-43bc-936a-d3edd26bed70) - [Baxalta US Inc.](https://www.keypedia.com/companies/baxalta-us-inc/dd00e45b-9175-4b17-82d5-b189a034a97f) - [Eli Lilly & Company](https://www.keypedia.com/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf) - [Ferring Microbiome Inc.](https://www.keypedia.com/companies/ferring-microbiome-inc/860d4130-d93a-4017-97ca-30033280de85) - [Latina Pharma S.p.A.](https://www.keypedia.com/companies/latina-pharma-spa/9cb7e758-39a0-4b4c-bfad-93d1468f5d38) - [Baxalta Belgium Manufacturing SA](https://www.keypedia.com/companies/baxalta-belgium-manufacturing-sa/61b3acce-a147-4f22-b13a-34bb436ea8e9) - [Nordmark Arzneimittel GMBH & Co. KG](https://www.keypedia.com/companies/nordmark-arzneimittel-gmbh-co-kg/871eb270-8517-4646-923a-b4d2eb0ea73b) - [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/9d02bb1e-32f9-45c5-9b90-f52622553c63) - [Changzhou Pharmaceutical Factory](https://www.keypedia.com/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4) ## Related Officers - [Tarun D. Mehta](https://www.keypedia.com/people/tarun-d-mehta/4fddfee9-7083-4089-b298-f7536b8d9b73) - [Investigator ](https://www.keypedia.com/people/lindsey-schwierjohann/3608e7c0-5bb9-49f0-844d-ddd6f6724fdb) - [recipient](https://www.keypedia.com/people/nicholas-m-buscher/04066620-0ea5-452c-9699-57c50350fa8e) - [company_representative](https://www.keypedia.com/people/andrea-lc-waymire/32c5f073-3edb-42f1-830b-d455d4c23573) - [company_representative](https://www.keypedia.com/people/garry-l-hedgepeth/354a986e-c609-4cfd-8787-85c3f9a3e5d1)